# [18F]FPyQCP PET Imaging of Fibroblast Activation Protein in Selected Oncology Indications

> **NCT07432633** · PHASE1,PHASE2 · RECRUITING · sponsor: **Blue Earth Diagnostics** · enrollment: 71 (estimated)

## Conditions studied

- Colorectal Cancer
- Epithelial Ovarian Cancer
- Gastric Cancer
- Invasive Lobular Breast Carcinoma
- Pancreatic Ductal Adenocarcinoma

## Interventions

- **DRUG:** [18F]FPyQCP

## Key facts

- **NCT ID:** NCT07432633
- **Lead sponsor:** Blue Earth Diagnostics
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1,PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2026-03-18
- **Primary completion:** 2028-01-31
- **Final completion:** 2028-01-31
- **Target enrollment:** 71 (ESTIMATED)
- **Last updated:** 2026-03-27

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07432633

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07432633, "[18F]FPyQCP PET Imaging of Fibroblast Activation Protein in Selected Oncology Indications". Retrieved via AI Analytics 2026-06-01 from https://api.ai-analytics.org/clinical/NCT07432633. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*